Lava raises €16M for gamma delta T cell platform

By Elizabeth S. Eaton | May 25, 2018 | 6:21 PM GMT

Lava Therapeutics B.V. ('s-Hertogenbosch, the Netherlands) raised €16 million ($18.8 million) on May 23 in a series B round

Read the full 191 word article

How to gain access

Continue reading with a
two-week free trial.